On October 3, 2023, Scinai Immunotherapeutics Ltd. closed the transaction. The transaction included participation from a single investor
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 USD | 0.00% | -2.20% | -26.10% |
1st Jan change | Capi. | |
---|---|---|
-26.10% | 1.91M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.47% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |
- Stock Market
- Equities
- SCNI Stock
- News Scinai Immunotherapeutics Ltd.
- Scinai Immunotherapeutics Ltd. announced that it has received $1.329254 million in funding